Antifungal Susceptibility in Dairy Cattle: Off-Scale MICs
The first whole-genome study of a filamentous fungus from bovine mastitis shows the isolate kept low MICs to most azoles yet jumped off-scale for the echinocandin class. The genome also carried intact toxin-building gene clusters, a reminder that fungal mastitis is an under-surveyed front in dairy health.
Quick answer
A bovine mastitis isolate of Aspergillus fumigatus showed low minimum inhibitory concentrations to amphotericin B, itraconazole, posaconazole, and voriconazole, but off-scale values above 8 micrograms per milliliter for three echinocandins. Whole-genome sequencing found no classic resistance mutation, pointing instead to a tolerance-like state. The work argues for genomic surveillance of fungal mastitis, not just bacterial.
Why antifungal susceptibility in dairy cattle deserves attention
Bovine mastitis is most often discussed as a bacterial problem, and antibiotics remain the primary treatment. That focus has a blind spot: fungi, especially Aspergillus species, also cause mycotic mastitis in dairy cattle and can drive real economic loss through lower milk yield, failed treatment, and culling in severe cases. The genomic side of fungal mastitis has stayed thin compared with bacteria.
The study fills part of that gap with the first genomic characterization of a filamentous fungus isolated from a cow with mastitis. For producers and their veterinarians, the point is not the single cow but the principle: fungal isolates can carry their own susceptibility and toxin profiles, and those profiles deserve tracking alongside bacterial resistance.
How the isolate was identified and sequenced
The team isolated strain DAH1043FM from bovine milk and confirmed it with molecular and genomic methods.
| Step | Detail |
|---|---|
| Source | Bovine milk sample from a mastitis case |
| Identification | ITS gene sequencing, 564 bp query, 99.82% identity to A. fumigatus reference |
| Genome | Average nucleotide identity 99.72% with reference A. fumigatus |
| Assembly | 1,044 high-confidence genes; BUSCO 94.9% complete |
| Repeated sequence | 723,898 bp, equal to 2.36% of the genome |
| Sequencing | Oxford Nanopore long-read, QC at Q10 and reads above 500 bp |
| Validation | Read-level concordance 100%, QUAL above 30, depth 45 to 68x |
ITS sequencing returned a 564 bp query with 99.82% identity and full coverage against the reference, placing the isolate firmly within A. fumigatus. The genome annotation reached 94.9% complete BUSCOs, with 91.4% single-copy and 3.5% duplicated, a sign of a clean, usable assembly.
The susceptibility table that matters
Minimum inhibitory concentrations were measured against eight antifungal drugs using a filamentous-fungus kit, with assays run in triplicate across three days.
| Antifungal drug | MIC, micrograms per milliliter |
|---|---|
| Amphotericin B | 0.5 |
| Itraconazole | 0.5 |
| Posaconazole | 0.12 |
| Voriconazole | 0.12 |
| Fluconazole | 128 |
| Anidulafungin | greater than 8 |
| Caspofungin | greater than 8 |
| Micafungin | greater than 8 |
The azoles and amphotericin B stayed at low MICs, with posaconazole and voriconazole the most active at 0.12. Fluconazole sat high at 128, and all three echinocandins landed off-scale above 8. Because no breakpoint exists for echinocandins against this fungus, the high values are read as reduced susceptibility rather than a clean resistance call.
The counterintuitive result: no mutation, yet off-scale
The expected cause of echinocandin failure is a mutation in the fks gene, the drug target. This isolate showed no significant hot-spot alteration in fks. That leaves the off-scale MICs without the classic explanation, so the authors argue for a tolerance-like or reduced-susceptibility state driven by regulatory adaptation, cell-wall salvage responses, or changed glucan-synthase expression.
This distinction is not academic. A tolerance state can still let a fungus persist under drug pressure without the tidy genetic signature labs usually hunt for. For mastitis management, it means susceptibility testing and genomics need to travel together: a clean fks gene does not by itself promise an echinocandin will work.
Toxin-building potential sat in the genome
The genome carried biosynthetic gene clusters for several secondary metabolites, scored by similarity to known pathways.
| Predicted cluster | Similarity to known pathway |
|---|---|
| Fumiquinazoline | 100% |
| Clavaric acid | 100% |
| Naphthopyrone | 100% |
| Gliotoxin | 84% |
| Fumagillin or fumagillol | 80% |
| Neosartoricin B | 80% |
| Trypacidin | 71% |
Gliotoxin, at 84% similarity, is a known virulence-associated metabolite in A. fumigatus. The presence of these clusters shows the isolate had the genomic capacity to build compounds tied to host interaction and tissue damage, even though their role inside the mammary gland was not tested in live animals.
What this means for dairy operations
Mycotic mastitis is harder to treat than bacterial mastitis and is easy to miss when culture focuses on bacteria. The study supports a few moves:
- Culture for fungi, as well as bacteria, when a mastitis case fails to respond to standard antibiotic therapy.
- Treat susceptibility results together with genomic data, because a clean resistance gene does not rule out reduced susceptibility.
- Build local surveillance of mastitis-associated fungi, since genome-level knowledge of this group is still limited.
- Keep antibiotic use measured, because indiscriminate and prolonged use is what drives the broader resistance problem the study cites.
Limitations to keep in view
The work examined a single bovine mastitis isolate, so its findings cannot be generalized across all mastitis-associated Aspergillus strains. The toxin clusters are predicted by sequence similarity, not confirmed by live-animal function. The echinocandin interpretation lacks an approved breakpoint, so the off-scale values are suggestive rather than a formal resistance classification.
Bottom line
Antifungal susceptibility in dairy cattle is an under-surveyed flank of mastitis control. This first genome of a mastitis-derived filamentous fungus showed low azole MICs but off-scale echinocandin values without a target mutation, plus intact toxin-building clusters. Tracking fungal isolates with both susceptibility testing and genomics is a practical step toward steadier, more measured mastitis treatment.
FAQ
What fungus was found in the milk?
The isolate was Aspergillus fumigatus, strain DAH1043FM, recovered from a cow with mastitis. ITS sequencing gave a 564 bp query with 99.82% identity and full coverage against the reference strain. Whole-genome comparison showed 99.72% average nucleotide identity. The result places it clearly within the A. fumigatus species.
Which drugs had the lowest MICs?
Posaconazole and voriconazole were the most active at 0.12 micrograms per milliliter, with amphotericin B and itraconazole both at 0.5. Fluconazole was weak at 128, far above the active azoles. The low azole values mean the isolate stayed sensitive to most drugs in that class despite the off-scale echinocandin result.
Why were echinocandins off-scale?
All three echinocandins, anidulafungin, caspofungin, and micafungin, showed MICs above 8 micrograms per milliliter, the top of the test. No fks target mutation explained it, so the authors propose a tolerance-like or reduced-susceptibility state from regulatory or cell-wall changes. The high values are read as reduced susceptibility, not proven resistance.
Does this mean the fungus is resistant?
Not in the classic sense. Resistance usually traces to a target-site mutation, and this isolate had none in the fks hot spots. The off-scale echinocandin MICs instead suggest a tolerance state that lets the fungus persist under drug pressure. Without an approved breakpoint, the result is suggestive rather than a formal resistance call.
What toxin clusters were in the genome?
The genome carried clusters for fumiquinazoline, clavaric acid, and naphthopyrone at 100% similarity, gliotoxin at 84%, and fumagillin, neosartoricin B at 80%, with trypacidin at 71%. Gliotoxin is a known virulence metabolite in A. fumigatus. The clusters show toxin-building capacity, not confirmed live-animal effect.
Why sequence the genome at all?
Genomic data explains susceptibility patterns that a plate test alone cannot, such as whether off-scale MICs come from a mutation or a tolerance state. The study used whole-genome sequencing to show the echinocandin result lacked a target mutation. It also mapped toxin clusters that shape host interaction and persistence.
How complete was the genome assembly?
The assembly reached 94.9% complete BUSCOs, with 91.4% single-copy and 3.5% duplicated, from 1,044 high-confidence genes. Repeated sequence made up 723,898 bp, or 2.36% of the genome. Read-level validation showed 100% concordance at depth 45 to 68x, supporting confidence in the calls from both axes.
Is fungal mastitis common in dairy cows?
The study notes mycotic mastitis linked to Aspergillus is reported often enough to cause real economic loss through lower milk, failed treatment, and culling. Genomic work on mastitis-associated fungi has lagged far behind bacteria. This isolate is described as the first genome of a filamentous fungus from a bovine mastitis case.
How is the sample collected?
Milk was collected after cleaning and disinfecting the teat with 70% ethanol, with no preservative added, and transported at 4 degrees Celsius within 2 hours. Bacterial culture on blood and MacConkey agar ran in parallel to check for co-infection. The fungal isolate was grown on Sabouraud dextrose agar with chloramphenicol at 35 degrees Celsius.
What is the treatment takeaway?
When a mastitis case fails standard antibiotic therapy, culture for fungi and read any susceptibility result next to genomic data. A clean resistance gene does not guarantee an echinocandin will work, because tolerance states exist. Local surveillance of antifungal susceptibility in dairy cattle remains thin and worth building.
Could this affect antibiotic use?
The study cites that prolonged, indiscriminate antibiotic use in mastitis drives antimicrobial resistance and lowers treatment effectiveness. Fungal mastitis that follows or co-occurs with bacterial cases adds pressure to use drugs carefully. Better diagnosis of the true agent supports more measured, targeted therapy on the farm.
What are the study limitations?
The work examined only one bovine mastitis isolate, so results do not generalize across all mastitis fungi. Toxin clusters are predicted by sequence similarity, not confirmed in live animals. The echinocandin interpretation lacks an approved breakpoint, leaving the off-scale values suggestive rather than a formal resistance classification.
